Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,253-9,264 of 10,661

Drug study icon

CompletedNCT00277667

Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States
Sponsor: Lindner Center of HOPE
Condition: Bipolarity

Other study type icon

CompletedNCT02488109

Refeeding to Optimize iNpatient Gains

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersOtherFrom 12 Years to 24 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: Eating disorders

Drug study icon

CompletedNCT00277654

Risperidone Monotherapy for anxiety

This study is completed in the United States. It is testing risperidone Monotherapy for anxiety.

In United States

Bipolarity, AnxietyDrugOver 18 Years

Countries: United States
Sponsor: Lindner Center of HOPE
Condition: Bipolarity, Anxiety

Drug study icon

Active Not RecruitingNCT06442462

SPG302 in Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Australia
Sponsor: Spinogenix
Condition: Schizophrenia

Drug study icon

CompletedNCT06545916

Sunobinop on Alcohol Consumption in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States, Romania
Sponsor: Knoa Pharma LLC
Condition: Addiction

Drug study icon

CompletedNCT06545929

Sunobinop on Craving in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Knoa Pharma LLC
Condition: Addiction

Drug study icon

CompletedNCT02392468

Safety study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in schizophrenia

This study is completed in the United States. It is testing Systemic and Ocular Safety and Pharmacokinetics of BI 409306 for schizophrenia.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

Drug study icon

CompletedNCT00103727

Talnetant Versus Placebo And Risperidone In Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: GlaxoSmithKline
Condition: Schizophrenia

Drug study icon

CompletedNCT06216132

the BIOPIN 6 Naltrexone Implant in Healthy Adults

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Akyso Therapeutics, LLC
Condition: Addiction

Behavioral study icon

CompletedNCT01686724

the Collaborative Life Skills Program

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 7 Years to 11 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: ADHD

Drug study icon

CompletedNCT03945175

The Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening

This study is completed in the United States. It focuses on ADHD.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: ADHD

Behavioral study icon

CompletedNCT00561340

the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 5 Years to 9 Years

Countries: United States
Sponsor: University of Nebraska
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.